|Bid||115.30 x 1000|
|Ask||115.31 x 800|
|Day's Range||114.96 - 116.93|
|52 Week Range||79.11 - 116.93|
|Beta (5Y Monthly)||0.81|
|PE Ratio (TTM)||39.64|
|Earnings Date||Jul 29, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||5.20 (4.48%)|
|Ex-Dividend Date||Apr 14, 2021|
|1y Target Est||123.78|
Ironwood (IRWD) witnesses strong demand for Linzess in the first quarter. However, outlook for 2021 misses market expectations. Stock down.
Is AbbVie stock a buy now that shares are recovering somewhat after the Food and Drug Administration requested additional data before considering new approvals for Rinvoq?
On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta's senior management team. Thank you, Jennifer, and good afternoon, everyone.